Showing 4,141 - 4,160 results of 4,174 for search 'Who's Who in America', query time: 0.22s Refine Results
  1. 4141

    Addressing the Maternal Mental Health Crisis Through a Novel Tech-Enabled Peer-to-Peer Driven Perinatal Collaborative Care Model by Bridget McKinney

    Published 2023-06-01
    “…This paper will analyze the current state of perinatal mental healthcare in America. It will introduce the Psychiatric Collaborative Care Model and demonstrate its effectiveness. …”
    Get full text
    Article
  2. 4142
  3. 4143
  4. 4144
  5. 4145
  6. 4146
  7. 4147
  8. 4148

    The Benefits and Burdens of Meat Consumption by Cynthia Coyle, Ashley McKinstry

    Published 2023-03-01
    “… - [1] Lisa, Andrew. History of America's Meat-Processing Industry. 18 Aug. 2020, https://stacker.com/stories/4402/history-americas-meat-processing-industry…”
    Get full text
    Article
  9. 4149

    Abstract 012: First‐line Stent Retriever Versus Contact Aspiration or Combined Technique for Posterior Cerebral Artery Occlusion EVT by Piers Klein, Thanh N Nguyen, Mohamad Abdalkader, Muhammad M Qureshi, Patrik Michel, Davide Strambo, Daniel Strbian, Christian Herweh, Markus A Möhlenbruch, Silja Räty, Marta Olivé‐Gadea, Marc Ribo, Marios Psychogios, Urs Fischer, Anh Nguyen, Joji Kuramatsu, David Haupenthal, Martin Köhrmann, Cornelius Deuschl, Jordi Kühne Escolà, Shadi Yaghi, Liqi Shu, Volker Puetz, Simon Nagel, Hend Abdelhamid, Negar Asdaghi, Judith Clark, Dominique P Cornelius Marterstock, Bruno Cunha, Guilherme Dabus, Jelle Demeestere, Shashvat Desai, Francesco Diana, Tobias Engelhorn, Johanna T Fifi, Isabel Fragata, Uta Hanning, Diogo Haussen, Ashutosh P Jadhav, Jessica Jesser, Maximilian Kaeder, Johannes Kaeshmacher, Daniel Kaiser, Kimmo Lappalainen, Italo L'Infante, Joao Pedro Marto, Hesham Masoud, Stavros Matsoukas, Volker Maus, Thomas R. Meinel, Lukas Meyer, Milena Miszczuk, Mahmoud Mohammaden, Maxim Mokin, Adnan Mujanovic, Raul Nogueira, Christian H Nolte, Sven Poli, Khouloud Poli, Joao Nuno Ramos, Christoph Riegler, Michele Romoli, Vasu Saini, Sergio A Salazar‐Marioni, Sunil A Sheth, Eberhard Siebert, James Siegler, Neil Suryadareva, Lieselotte Vandewalle, Pekka Virtanen, Charlotte S Weyland, Shadi Yaghi

    Published 2023-11-01
    “…Results There were 326 patients who met inclusion criteria, consisting of 56.1% male, median age 75 (IQR 65‐82) years and median NIHSS 8 (5‐12). …”
    Get full text
    Article
  10. 4150
  11. 4151
  12. 4152
  13. 4153
  14. 4154

    The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network by Hossain, MS, Commons, RJ, Douglas, NM, Thriemer, K, Alemayehu, BH, Amaratunga, C, Anvikar, AR, Ashley, EA, Asih, PBS, Carrara, VI, Lon, C, D’Alessandro, U, Davis, TME, Dondorp, AM, Edstein, MD, Fairhurst, RM, Ferreira, MU, Hwang, J, Janssens, B, Karunajeewa, H, Kiechel, JR, Ladeia-Andrade, S, Laman, M, Mayxay, M, McGready, R, Moore, BR, Mueller, I, Newton, PN, Thuy-Nhien, NT, Noedl, H, Nosten, F, Phyo, AP, Poespoprodjo, JR, Saunders, DL, Smithuis, F, Spring, MD, Stepniewska, K, Suon, S, Suputtamongkol, Y, Syafruddin, D, Tran, HT, Valecha, N, Van Herp, M, Van Vugt, M, White, NJ, Guerin, PJ, Simpson, JA, Price, RN

    Published 2020
    “…In multivariable analyses, the highest rate of P. vivax parasitaemia over 42 days of follow-up was in patients residing in areas of short relapse periodicity (adjusted hazard ratio [AHR] = 6.2, 95% CI 2.0–19.5; p = 0.002); patients treated with AL (AHR = 6.2, 95% CI 4.6–8.5; p < 0.001), AA (AHR = 2.3, 95% CI 1.4–3.7; p = 0.001), or AM (AHR = 1.4, 95% CI 1.0–1.9; p = 0.028) compared with DP; and patients who did not clear their initial parasitaemia within 2 days (AHR = 1.8, 95% CI 1.4–2.3; p < 0.001). …”
    Journal article
  15. 4155

    Annotated catalogue of the Tachinidae (Insecta, Diptera) of Chile by James E. O'Hara, D. Monty Wood, Christian R. González

    Published 2021-10-01
    “…The history of tachinid collectors in Chile and authors who have contributed to the systematic knowledge of Chilean tachinids is extensively reviewed. …”
    Get full text
    Article
  16. 4156

    Tlacoqualli in Monequi "The Center Good" by Ried Mackay

    Published 2022-10-01
    “…BACKGROUND Indigenous American philosophy has strong foundations throughout North and South America[1] that can provide a base for developing Indigenous-focused bioethics. …”
    Get full text
    Article
  17. 4157
  18. 4158

    Should the Food and Drug Administration Limit Placebo-Controlled Trials? by Max Goodman, Connor Pedersen

    Published 2022-07-01
    “…Condition Three: Compelling Methodological Reasoning Finally, the FDA authorizes placebo use in cases where for compelling scientifically sound methodological reasons, the use of placebo is necessary to determine the efficacy or safety of an intervention, and the parties who receive placebo or no treatment will not be subject to any risk of serious or irreversible harm. …”
    Get full text
    Article
  19. 4159

    Should the Food and Drug Administration Limit Placebo-Controlled Trials? by Max Goodman, Connor Pedersen

    Published 2022-07-01
    “…Condition Three: Compelling Methodological Reasoning Finally, the FDA authorizes placebo use in cases where for compelling scientifically sound methodological reasons, the use of placebo is necessary to determine the efficacy or safety of an intervention, and the parties who receive placebo or no treatment will not be subject to any risk of serious or irreversible harm. …”
    Get full text
    Article
  20. 4160

    Prevalence of lung cancer in chronic obstructive pulmonary disease: A systematic review and meta-analysis by Guixiang Zhao, Guixiang Zhao, Xuanlin Li, Xuanlin Li, Siyuan Lei, Siyuan Lei, Hulei Zhao, Hulei Zhao, Hulei Zhao, Hailong Zhang, Hailong Zhang, Hailong Zhang, Jiansheng Li, Jiansheng Li, Jiansheng Li

    Published 2022-09-01
    “…There were also differences in regional distribution, with the highest prevalence in the Western Pacific region at 7.78% (95% CI: 5.06–10.5%), followed by the Americas at 3.25% (95% CI: 0.88–5.61%) and Europe at 3.21% (95% CI: 2.36–4.06%).ConclusionsThis meta-analysis shows that patients with COPD have a higher risk of developing lung cancer than those without COPD. …”
    Get full text
    Article